Kai Shen
State Key Laboratory Of Bioreactor Engineering
Shanghai, 200237, China
Shanghai, 200237, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Low-PSMA hormone-sensitive prostate cancer: a distinct clinical and molecular state.
Journal: Molecular medicine (Cambridge, Mass.)
Published: May 19, 2026
Distinct prognostic value of [18F]FDG PET and [68Ga]Ga-PSMA-11 PET in advanced hormone-sensitive prostate cancer.
Journal: Communications medicine
Published: August 27, 2025
Development of an in vitro multi-enzyme system for efficient one-pot biosynthesis of sorbitol from fructose-6-phosphate.
Journal: Bioresources and bioprocessing
Published: June 30, 2025
Targeting the CCL5/CCR5 axis in tumor-stromal crosstalk to overcome cisplatin resistance in neuroendocrine prostate cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 22, 2025
Population Pharmacokinetics and Pharmacodynamics Modeling for the Use of Recaticimab in Healthy Volunteers and Patients with Hypercholesterolemia.
Journal: Clinical pharmacokinetics
Published: April 17, 2025
snoRNP RRP9 Promotes Prostate Cancer Cell Proliferation and Migration via SQSTM1.
Journal: Advanced biology
Published: March 06, 2025
Evaluation of the pharmacokinetic interactions of montmorillonite powder or loperamide on pyrotinib in healthy volunteers.
Journal: Frontiers in pharmacology
Published: January 22, 2025
Prognostic value of [18F]FDG PET/CT in metastatic hormone-sensitive prostate cancer at initial diagnosis: a retrospective cohort study.
Journal: Annals of medicine
Published: October 11, 2024
A phase 1, randomized, double-blind, placebo-controlled, dose escalation study to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of SHR-1905, a long-acting anti-thymic stromal lymphopoietin antibody, in healthy subjects.
Journal: Frontiers in pharmacology
Published: March 14, 2024
Effect of Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of SHR4640, a Selective Human Urate Transporter 1 Inhibitor.
Journal: Journal of clinical pharmacology
Published: March 13, 2024
Understanding Photo(electro)catalysts for Energy Conversion via Operando Functional Imaging.
Journal: Chemical & biomedical imaging
Published: June 27, 2023
Last Updated: 09/26/2026